Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Abca1 | |
NM_013454 |
ATP-binding cassette, sub-family A (ABC1), member 1 (Abca1), mRNA [NM_013454] |
KLA | .69 |
.60 |
.65 |
.69 |
1.48 |
1.80 |
1.46 |
| ATP | 1.23 |
1.10 |
.81 |
1.24 |
2.92 |
5.72 |
1.45 |
| KLA/ATP | .77 |
.62 |
.54 |
1.00 |
2.34 |
4.04 |
2.36 |
|
Abcg5 | |
NM_031884 |
ATP-binding cassette, sub-family G (WHITE), member 5 (Abcg5), mRNA [NM_031884] |
KLA | 1.03 |
1.03 |
1.03 |
1.03 |
.98 |
.94 |
.99 |
| ATP | 1.14 |
.98 |
.96 |
.94 |
1.04 |
.99 |
.96 |
| KLA/ATP | .98 |
1.00 |
.99 |
.92 |
.91 |
1.04 |
1.03 |
|
Abcg8 | |
NM_026180 |
ATP-binding cassette, sub-family G (WHITE), member 8 (Abcg8), mRNA [NM_026180] |
KLA | 1.01 |
1.03 |
1.03 |
.99 |
1.02 |
1.06 |
.98 |
| ATP | .99 |
1.00 |
1.01 |
1.00 |
.97 |
1.04 |
1.05 |
| KLA/ATP | .98 |
.94 |
1.06 |
1.01 |
.99 |
.98 |
1.08 |
|
Acat2 | |
NM_009338 |
acetyl-Coenzyme A acetyltransferase 2 (Acat2), mRNA [NM_009338] |
KLA | 1.14 |
1.13 |
1.22 |
1.29 |
1.10 |
.93 |
.81 |
| ATP | 1.04 |
1.05 |
1.16 |
1.35 |
1.20 |
1.53 |
1.16 |
| KLA/ATP | 1.19 |
1.19 |
1.41 |
1.29 |
1.13 |
.92 |
.71 |
|
Agpat1 | |
NM_018862 |
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (Agpat1), mRNA [NM_018862] |
KLA | 1.24 |
1.27 |
1.16 |
1.37 |
1.37 |
1.51 |
1.65 |
| ATP | .99 |
1.09 |
1.19 |
1.29 |
1.20 |
1.03 |
1.27 |
| KLA/ATP | 1.27 |
1.33 |
1.37 |
1.49 |
1.28 |
1.17 |
1.55 |
|
Agpat2 | |
NM_026212 |
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (Agpat2), mRNA [NM_026212] |
KLA | .88 |
.86 |
1.05 |
1.00 |
1.28 |
1.13 |
1.05 |
| ATP | 1.06 |
1.15 |
.95 |
1.09 |
.97 |
1.22 |
1.04 |
| KLA/ATP | .96 |
.94 |
.73 |
.87 |
.78 |
.97 |
.63 |
|
Apoa1 | |
NM_009692 |
apolipoprotein A-I (Apoa1), mRNA [NM_009692] |
KLA | .99 |
1.00 |
1.00 |
1.02 |
1.01 |
1.02 |
.98 |
| ATP | 1.00 |
1.00 |
1.02 |
1.16 |
1.03 |
1.04 |
1.01 |
| KLA/ATP | 1.00 |
1.03 |
1.07 |
1.23 |
1.10 |
1.05 |
.98 |
|
Apoa4 | |
NM_007468 |
apolipoprotein A-IV (Apoa4), mRNA [NM_007468] |
KLA | .95 |
.99 |
.93 |
.99 |
1.03 |
.99 |
1.02 |
| ATP | .98 |
1.07 |
.99 |
1.00 |
.99 |
1.04 |
1.01 |
| KLA/ATP | 1.00 |
.91 |
.93 |
1.01 |
1.02 |
1.01 |
1.03 |
|
Apob | |
NM_009693 |
apolipoprotein B (Apob), mRNA [NM_009693] |
KLA | 1.02 |
.97 |
.99 |
.99 |
1.00 |
1.01 |
.99 |
| ATP | .98 |
.96 |
1.05 |
1.06 |
1.04 |
.99 |
1.06 |
| KLA/ATP | .98 |
1.07 |
.97 |
1.01 |
.98 |
1.05 |
1.00 |
|
Cd36 | |
L23108 |
CD36 antigen mRNA, complete cds. [L23108] |
KLA | .75 |
.74 |
.73 |
.57 |
.51 |
.40 |
.54 |
| ATP | .94 |
.93 |
.74 |
.61 |
.63 |
1.01 |
2.07 |
| KLA/ATP | .70 |
.67 |
.53 |
.47 |
.40 |
.58 |
1.13 |
|
Cd36 | |
NM_007643 |
CD36 antigen (Cd36), mRNA [NM_007643] |
KLA | .70 |
.75 |
.67 |
.54 |
.45 |
.35 |
.42 |
| ATP | 1.06 |
1.04 |
.73 |
.58 |
.62 |
.81 |
1.44 |
| KLA/ATP | .83 |
.73 |
.45 |
.46 |
.35 |
.45 |
.82 |
|
Cel | |
NM_009885 |
carboxyl ester lipase (Cel), mRNA [NM_009885] |
KLA | 1.06 |
1.02 |
1.06 |
1.07 |
1.07 |
1.08 |
1.11 |
| ATP | 1.01 |
1.04 |
1.18 |
1.09 |
1.09 |
1.21 |
1.09 |
| KLA/ATP | 1.06 |
.97 |
1.24 |
1.16 |
1.19 |
1.21 |
1.10 |
|
Clps | |
NM_025469 |
colipase, pancreatic (Clps), mRNA [NM_025469] |
KLA | 1.03 |
1.04 |
1.04 |
1.02 |
1.04 |
1.06 |
1.08 |
| ATP | .97 |
.98 |
1.04 |
1.05 |
1.00 |
1.01 |
1.05 |
| KLA/ATP | .98 |
.96 |
1.08 |
1.09 |
1.12 |
.93 |
1.04 |
|
Dgat1 | |
NM_010046 |
diacylglycerol O-acyltransferase 1 (Dgat1), mRNA [NM_010046] |
KLA | 1.05 |
1.03 |
1.09 |
.93 |
1.04 |
1.06 |
1.42 |
| ATP | 1.06 |
1.12 |
1.23 |
1.57 |
1.34 |
2.37 |
1.50 |
| KLA/ATP | 1.11 |
1.10 |
.97 |
1.24 |
1.10 |
2.12 |
2.03 |
|
Dgat2 | |
NM_026384 |
diacylglycerol O-acyltransferase 2 (Dgat2), mRNA [NM_026384] |
KLA | 2.44 |
2.65 |
2.86 |
3.52 |
3.45 |
2.83 |
1.41 |
| ATP | .97 |
.97 |
1.07 |
1.81 |
1.69 |
2.29 |
1.29 |
| KLA/ATP | 2.21 |
2.45 |
2.36 |
2.76 |
3.16 |
4.51 |
3.63 |
|
Fabp1 | |
NM_017399 |
fatty acid binding protein 1, liver (Fabp1), mRNA [NM_017399] |
KLA | 1.07 |
1.05 |
1.02 |
.97 |
1.02 |
1.00 |
1.02 |
| ATP | 1.04 |
1.04 |
1.06 |
.99 |
.99 |
.97 |
.90 |
| KLA/ATP | .96 |
1.03 |
1.02 |
.99 |
.94 |
.97 |
.94 |
|
Fabp2 | |
NM_007980 |
fatty acid binding protein 2, intestinal (Fabp2), mRNA [NM_007980] |
KLA | 1.87 |
1.96 |
2.32 |
1.82 |
2.37 |
1.80 |
1.89 |
| ATP | 1.05 |
1.10 |
1.03 |
1.26 |
1.09 |
1.07 |
1.37 |
| KLA/ATP | 2.04 |
2.14 |
1.41 |
1.96 |
1.38 |
1.34 |
1.69 |
|
Got2 | |
NM_010325 |
glutamate oxaloacetate transaminase 2, mitochondrial (Got2), nuclear gene encoding mitochondrial protein, mRNA [NM_010325] |
KLA | .84 |
.86 |
.88 |
.75 |
.75 |
.63 |
.61 |
| ATP | 1.02 |
1.12 |
.98 |
1.15 |
.98 |
.67 |
.86 |
| KLA/ATP | .92 |
.89 |
.75 |
.89 |
.68 |
.70 |
.77 |
|
Lipf | |
NM_026334 |
lipase, gastric (Lipf), mRNA [NM_026334] |
KLA | .98 |
1.00 |
1.09 |
1.07 |
1.04 |
1.12 |
1.11 |
| ATP | .96 |
.98 |
1.02 |
1.03 |
1.00 |
.99 |
1.05 |
| KLA/ATP | 1.03 |
1.05 |
.99 |
1.03 |
1.04 |
1.08 |
1.05 |
|
Mm.21249 2 | |
46402232 |
Unknown |
KLA | 1.00 |
1.02 |
.97 |
1.02 |
1.09 |
1.02 |
1.03 |
| ATP | .99 |
1.06 |
1.00 |
.99 |
1.00 |
1.09 |
1.01 |
| KLA/ATP | .97 |
.99 |
1.01 |
1.04 |
1.05 |
1.00 |
.93 |
|
Mm.24244
| |
23956161 |
Unknown |
KLA | 1.04 |
1.00 |
.96 |
1.04 |
1.53 |
1.13 |
1.09 |
| ATP | 1.17 |
1.30 |
.97 |
1.10 |
1.09 |
1.26 |
1.10 |
| KLA/ATP | .92 |
1.07 |
.82 |
.97 |
.80 |
.96 |
.74 |
|
Mm.27737 6 | |
90568037 |
Unknown |
KLA | .66 |
.59 |
.62 |
.83 |
1.44 |
1.94 |
1.41 |
| ATP | .95 |
.79 |
.79 |
1.03 |
2.52 |
6.30 |
1.26 |
| KLA/ATP | .52 |
.48 |
.55 |
.90 |
2.69 |
4.57 |
1.99 |
|
Mm.28873
| |
110431340 |
Unknown |
KLA | .79 |
.72 |
.69 |
.71 |
.44 |
.32 |
.37 |
| ATP | .89 |
.88 |
1.17 |
.98 |
1.11 |
.98 |
.73 |
| KLA/ATP | .67 |
.72 |
.87 |
.74 |
.75 |
.53 |
.30 |
|
Mm.71913
| |
118130231 |
Unknown |
KLA | .93 |
1.00 |
1.06 |
.97 |
.95 |
.98 |
1.04 |
| ATP | 1.00 |
.98 |
1.08 |
1.02 |
.92 |
.90 |
.99 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.99 |
.99 |
.99 |
1.01 |
|
Mogat2 | |
NM_177448 |
monoacylglycerol O-acyltransferase 2 (Mogat2), mRNA [NM_177448] |
KLA | .96 |
.98 |
1.08 |
1.04 |
1.11 |
.99 |
1.00 |
| ATP | 1.15 |
1.06 |
1.20 |
1.19 |
1.24 |
1.48 |
1.06 |
| KLA/ATP | .91 |
.97 |
1.25 |
1.24 |
1.47 |
1.31 |
1.22 |
|
Mttp | |
NM_008642 |
microsomal triglyceride transfer protein (Mttp), mRNA [NM_008642] |
KLA | 1.09 |
1.17 |
1.31 |
1.23 |
1.36 |
1.19 |
1.19 |
| ATP | 1.04 |
1.09 |
.98 |
.90 |
.86 |
.91 |
1.13 |
| KLA/ATP | 1.19 |
1.15 |
1.01 |
1.03 |
.96 |
.94 |
1.27 |
|
Npc1l1 | |
AK078947 |
adult male cecum cDNA, RIKEN full-length enriched library, clone:9130221N23 product:similar to NIEMANN-PICK C3 PROTEIN [Homo sapiens], full insert sequence [AK078947] |
KLA | .93 |
.91 |
1.05 |
.99 |
.98 |
1.06 |
.92 |
| ATP | .99 |
.98 |
1.09 |
.98 |
1.12 |
1.08 |
.98 |
| KLA/ATP | .97 |
.97 |
.96 |
.93 |
.98 |
.96 |
1.03 |
|
Pla2g10 | |
NM_011987 |
phospholipase A2, group X (Pla2g10), mRNA [NM_011987] |
KLA | .99 |
1.11 |
1.02 |
.99 |
1.00 |
1.01 |
1.02 |
| ATP | 1.02 |
.97 |
1.01 |
1.03 |
1.00 |
1.02 |
1.04 |
| KLA/ATP | 1.04 |
.96 |
.95 |
1.04 |
1.06 |
1.05 |
1.01 |
|
Pla2g12a
| |
NM_023196 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] |
KLA | 1.03 |
1.06 |
.97 |
1.00 |
.78 |
.75 |
.92 |
| ATP | .91 |
.99 |
1.29 |
1.30 |
1.20 |
1.48 |
1.71 |
| KLA/ATP | .92 |
.99 |
1.19 |
1.16 |
1.06 |
1.12 |
1.36 |
|
Pla2g12a
| |
NM_183423 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] |
KLA | .90 |
1.00 |
.87 |
.95 |
.76 |
.68 |
.88 |
| ATP | .96 |
.94 |
1.26 |
1.24 |
1.19 |
1.47 |
1.88 |
| KLA/ATP | .89 |
.90 |
1.08 |
1.07 |
1.06 |
1.02 |
1.59 |
|
Pla2g12b
| |
NM_023530 |
phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] |
KLA | .98 |
.95 |
1.05 |
.99 |
1.03 |
.99 |
.94 |
| ATP | 1.02 |
1.04 |
1.07 |
1.05 |
.92 |
1.04 |
1.00 |
| KLA/ATP | .98 |
.92 |
1.10 |
1.11 |
1.09 |
1.03 |
1.04 |
|
Pla2g1b | |
NM_011107 |
phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] |
KLA | 1.00 |
1.01 |
1.01 |
1.11 |
1.00 |
1.28 |
1.00 |
| ATP | .98 |
1.03 |
1.09 |
1.03 |
1.01 |
1.02 |
1.04 |
| KLA/ATP | .93 |
.94 |
1.01 |
1.00 |
.94 |
1.09 |
1.07 |
|
Pla2g2a | |
NM_001082531 |
phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] |
KLA | 1.08 |
.99 |
1.00 |
1.06 |
.98 |
1.01 |
.94 |
| ATP | 1.07 |
.98 |
1.04 |
1.06 |
.90 |
.98 |
.98 |
| KLA/ATP | .98 |
1.03 |
1.00 |
1.04 |
.94 |
.97 |
.96 |
|
Pla2g2c | |
NM_008868 |
phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] |
KLA | .98 |
.99 |
1.05 |
.98 |
1.01 |
1.00 |
1.04 |
| ATP | 1.08 |
1.06 |
1.09 |
.93 |
.92 |
.92 |
1.00 |
| KLA/ATP | 1.03 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
1.02 |
|
Pla2g2d | |
NM_011109 |
phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] |
KLA | 1.02 |
1.02 |
.99 |
.99 |
1.00 |
1.01 |
1.00 |
| ATP | .95 |
1.11 |
1.10 |
1.11 |
.98 |
.99 |
1.12 |
| KLA/ATP | 1.02 |
1.00 |
1.19 |
1.11 |
1.00 |
.96 |
1.01 |
|
Pla2g2e | |
NM_012044 |
phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] |
KLA | .78 |
.75 |
.74 |
.72 |
.62 |
.69 |
1.40 |
| ATP | 1.06 |
1.00 |
.92 |
1.04 |
.83 |
.76 |
3.74 |
| KLA/ATP | .78 |
.80 |
.69 |
.74 |
.70 |
.74 |
2.24 |
|
Pla2g2f | |
NM_012045 |
phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] |
KLA | 1.02 |
.99 |
1.03 |
1.01 |
1.00 |
.95 |
.99 |
| ATP | 1.01 |
1.06 |
1.11 |
.97 |
1.09 |
1.11 |
.99 |
| KLA/ATP | 1.10 |
1.05 |
1.04 |
.95 |
1.04 |
1.01 |
.96 |
|
Pla2g3 | |
NM_172791 |
phospholipase A2, group III (Pla2g3), mRNA [NM_172791] |
KLA | 1.04 |
1.05 |
1.02 |
1.01 |
1.04 |
1.11 |
1.00 |
| ATP | .96 |
.97 |
1.10 |
.91 |
.99 |
.97 |
1.08 |
| KLA/ATP | 1.03 |
1.11 |
1.10 |
.98 |
.95 |
.98 |
1.07 |
|
Pla2g5 | |
NM_011110 |
phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] |
KLA | .65 |
.62 |
.56 |
.53 |
.62 |
1.60 |
3.01 |
| ATP | .90 |
.82 |
.88 |
1.69 |
1.82 |
1.26 |
6.32 |
| KLA/ATP | .63 |
.59 |
.65 |
.63 |
.91 |
1.56 |
5.59 |
|
Pnlip | |
AK007357 |
10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357] |
KLA | .95 |
1.03 |
1.02 |
1.02 |
1.04 |
1.06 |
1.10 |
| ATP | 1.05 |
1.00 |
.95 |
1.10 |
1.00 |
1.03 |
1.02 |
| KLA/ATP | 1.02 |
1.00 |
.89 |
1.09 |
1.09 |
1.06 |
1.06 |
|
Pnlip | |
NM_026925 |
pancreatic lipase (Pnlip), mRNA [NM_026925] |
KLA | 1.04 |
.97 |
1.04 |
1.00 |
1.02 |
.99 |
.97 |
| ATP | 1.04 |
1.04 |
1.04 |
.96 |
.95 |
1.02 |
.97 |
| KLA/ATP | .99 |
.95 |
.97 |
.99 |
.96 |
.93 |
1.00 |
|
Pnliprp1
| |
NM_018874 |
pancreatic lipase related protein 1 (Pnliprp1), mRNA [NM_018874] |
KLA | .99 |
.95 |
.96 |
.99 |
.94 |
.96 |
1.01 |
| ATP | 1.00 |
1.00 |
.98 |
.96 |
.99 |
.87 |
1.09 |
| KLA/ATP | 1.01 |
1.06 |
1.01 |
1.02 |
1.03 |
.96 |
.92 |
|
Pnliprp2
| |
NM_011128 |
pancreatic lipase-related protein 2 (Pnliprp2), mRNA [NM_011128] |
KLA | 1.01 |
.97 |
1.02 |
1.07 |
1.08 |
.98 |
1.00 |
| ATP | 1.05 |
1.08 |
.98 |
1.02 |
1.00 |
1.00 |
1.02 |
| KLA/ATP | 1.05 |
1.04 |
.96 |
.99 |
1.01 |
1.03 |
1.05 |
|
Ppap2a | |
NM_008903 |
phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903] |
KLA | 2.62 |
2.86 |
4.01 |
5.61 |
7.84 |
10.88 |
16.35 |
| ATP | 1.01 |
1.02 |
1.09 |
1.28 |
1.27 |
2.38 |
1.44 |
| KLA/ATP | 2.78 |
2.78 |
2.99 |
3.43 |
2.85 |
3.59 |
6.59 |
|
Ppap2b | |
NM_080555 |
phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555] |
KLA | 2.73 |
2.72 |
2.65 |
2.39 |
1.07 |
1.48 |
3.26 |
| ATP | .99 |
.97 |
1.60 |
2.76 |
18.64 |
27.23 |
9.19 |
| KLA/ATP | 2.69 |
2.80 |
4.36 |
4.20 |
14.33 |
15.32 |
17.91 |
|
Ppap2c | |
NM_015817 |
phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817] |
KLA | .94 |
.88 |
.91 |
.79 |
.65 |
.46 |
.51 |
| ATP | 1.01 |
1.03 |
1.00 |
1.12 |
1.24 |
.90 |
.83 |
| KLA/ATP | .95 |
.93 |
.87 |
.95 |
.79 |
.63 |
.43 |
|
Scarb1 | |
NM_016741 |
scavenger receptor class B, member 1 (Scarb1), mRNA [NM_016741] |
KLA | .62 |
.60 |
.60 |
.51 |
.45 |
.40 |
.48 |
| ATP | 1.04 |
1.14 |
.68 |
.89 |
.53 |
.46 |
.82 |
| KLA/ATP | .73 |
.67 |
.40 |
.55 |
.34 |
.30 |
.39 |
|
Slc27a4 | |
NM_011989 |
solute carrier family 27 (fatty acid transporter), member 4 (Slc27a4), mRNA [NM_011989] |
KLA | .94 |
.93 |
.97 |
.87 |
.91 |
.97 |
1.23 |
| ATP | 1.05 |
1.02 |
.82 |
.75 |
.76 |
1.73 |
1.49 |
| KLA/ATP | 1.05 |
1.01 |
.78 |
.82 |
.75 |
1.31 |
2.26 |
|